View by Specialty

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

Leukemia News

SPONSORED CONTENT
Save
SPONSORED CONTENT
January 12, 2023
3 min read
Save

Novel T-cell therapy effective against common viruses after stem cell transplantation

Novel T-cell therapy effective against common viruses after stem cell transplantation

Posoleucel demonstrated encouraging efficacy against common viral infections among patients who underwent allogeneic hematopoietic stem cell transplantation, according to phase 2 study results published in Clinical Cancer Research.

SPONSORED CONTENT
January 11, 2023
4 min watch
Save

Cumulative anesthesia exposure linked to impaired neurocognitive function in pediatric ALL

Cumulative anesthesia exposure linked to impaired neurocognitive function in pediatric ALL

NEW ORLEANS — Cumulative anesthesia exposure appeared associated with impairments in neurocognitive function among children with high-risk acute lymphoblastic leukemia, according to study results presented at ASH Annual Meeting and Exposition.

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

SPONSORED CONTENT
January 09, 2023
2 min watch
Save

VIDEO: ASAP trial 'could challenge standard of care' for relapsed/refractory AML

VIDEO: ASAP trial 'could challenge standard of care' for relapsed/refractory AML

NEW ORLEANS — In this video perspective, Richard M Stone, MD, discusses data from the randomized phase 3 ASAP trial, which was presented at ASH Annual Meeting and Exposition.

SPONSORED CONTENT
January 05, 2023
2 min watch
Save

VIDEO: Blinatumomab 'clearly positive' for minimal residual disease-negative ALL

VIDEO: Blinatumomab 'clearly positive' for minimal residual disease-negative ALL

NEW ORLEANS — In this video perspective, Richard M. Stone, MD, discusses research results on blinatumomab presented at ASH Annual Meeting and Exposition.

SPONSORED CONTENT
January 04, 2023
2 min read
Save

Imetelstat confers durable transfusion independence in lower-risk myelodysplastic syndrome

Imetelstat confers durable transfusion independence in lower-risk myelodysplastic syndrome

Imetelstat conferred a “highly statistically significant and clinically meaningful benefit” vs. placebo in enabling certain patients with myelodysplastic syndrome to achieve transfusion independence, according to the agent’s manufacturer.

SPONSORED CONTENT
January 03, 2023
3 min read
Save

Novel regimen significantly lowers GVHD risk after reduced-intensity allogeneic HSCT

Novel regimen significantly lowers GVHD risk after reduced-intensity allogeneic HSCT

NEW ORLEANS — A regimen containing post-transplant cyclophosphamide significantly lowered graft-versus-host disease risk among adults who underwent reduced-intensity allogeneic hematopoietic stem cell transplant, study results showed.

SPONSORED CONTENT
January 03, 2023
4 min watch
Save

Tool may help identify which patients with clonal hematopoiesis will develop cancer

Tool may help identify which patients with clonal hematopoiesis will develop cancer

NEW ORLEANS — A new clinical tool can help identify which patients with clonal hematopoiesis are at highest risk for progression to cancer, according to study results presented at ASH Annual Meeting and Exposition.

SPONSORED CONTENT
December 31, 2022
6 min watch
Save

Combination may benefit certain patients with TP53-mutated myelodysplastic syndrome

Combination may benefit certain patients with <i>TP53</i>-mutated myelodysplastic syndrome

NEW ORLEANS — A higher burden of mutant TP53 cells connoted poorer risk among adults with intermediate- or high-risk myelodysplastic syndrome, according to study results presented at ASH Annual Meeting and Exposition.

SPONSORED CONTENT
December 30, 2022
2 min read
Save

BLOG: CAR T cells for long-term cure in pediatric ALL

BLOG: CAR T cells for long-term cure in pediatric ALL

Chimeric antigen receptor T-cell therapy targeting CD19 is highly effective for inducing remission among patients with relapsed or refractory B-cell acute lymphoblastic leukemia.

SPONSORED CONTENT
December 29, 2022
1 min read
Save

ASH recognizes Choosing Wisely, Guideline Implementation champions

ASH recognizes Choosing Wisely, Guideline Implementation champions

ASH recognized three Choosing Wisely champions and three guideline implementation champions at this year’s ASH Annual Meeting and Exposition.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails